21 CFR Part 201
LABELING
June 25, 2020
Subpart
A
General Labeling Provisions
Subpart
B
Labeling Requirements for Prescription Drugs and/or Insulin
Subpart
C
Labeling Requirements for Over-the-Counter Drugs
Subpart
D
Exemptions From Adequate Directions for Use
Subpart
E
Other Exemptions
Subpart
F
Labeling Claims for Drugs in Drug Efficacy Study
Subpart
G
Specific Labeling Requirements for Specific Drug Products
Appendix
A
Examples of Graphic Enhancements Used by FDA